ÂÜÀòÂÒÂ×

Erik Wold is currently the Vice President - Head of CMC at Kisbee Therapeutics. Prior to this role, Erik held positions at ContraFect Corp and WuXi Advanced Therapies specializing in Analytical Development and Quality Control. Erik's educational background includes a Ph.D. in Cell and Molecular Biology from Scripps Research and a Bachelor's Degree in Chemistry from Western Washington University.